Fat digestion using RELiZORB in children with short bowel syndrome who are dependent on parenteral nutrition: Protocol for a 90-day, phase 3, open labeled study.

Saved in:
Bibliographic Details
Title: Fat digestion using RELiZORB in children with short bowel syndrome who are dependent on parenteral nutrition: Protocol for a 90-day, phase 3, open labeled study.
Authors: Tsikis ST; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Fligor SC; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Mitchell PD; Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts, United States of America., Hirsch TI; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Carbeau S; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., First E; Alcresta Therapeutics, Newton, Massachusetts, United States of America., Loring G; Alcresta Therapeutics, Newton, Massachusetts, United States of America., Rudie C; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Freedman SD; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America., Martin CR; Division of Neonatology, Weill Cornell Medicine, New York City, New York, United States of America., Gura KM; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Pharmacy, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Puder M; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Source: PloS one [PLoS One] 2023 Mar 01; Vol. 18 (3), pp. e0282248. Date of Electronic Publication: 2023 Mar 01 (Print Publication: 2023).
Publication Type: Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0282248